Article
Identification of human butyrylcholinesterase organophosphate-resistant variants through a novel mammalian enzyme functional screen.
The Journal of pharmacology and experimental therapeutics - 1 Dec 2012
Zhang Jun, Chen Sigeng, Ralph Erik C, Dwyer Mary, Cashman John R
Abstract excerpt
Human butyrylcholinesterase (hBChE) is currently being developed as a detoxication enzyme for the catalytic hydrolysis or stoichiometric binding of organophosphates (OPs). Previously, rationally designed hBChE mutants (G117H and E197Q) were reported in the literature and showed the feasibility of engineering OP hydrolytic functional activity into hBChE. However, the OP hydrolysis rate for G117H is too low for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
